type2 DM
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Japanese individuals with type 2 diabetes, untreated or receiving biguanides or sulfonylureas. Inclusion criteria were as follows: Age 40-75 years, HbA1c 12.0% or less, and BMI 40 kg/m2 or less.
Exclusion criteria
Exclusion criteria: Subjects with type 1 diabetes, severe diabetic autonomic neuropathy, gastrointestinal tract disease including gastroparesis, history of gastrointestinal operation, cardiac disease, pulmonary disease, pancreatic disease, thyroid disease, liver disease, renal disease, alcohol or drug abuse, anti-diabetes drugs other than biguanides or sulfonylureas, diabetogenic medication, malignancy, or pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in glucose, insulin, and gastric emptying rate after administration of GLP-1RA for 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in glucose, insulin, and gastric emptying rate after administration of GLP-1RA for 12 weeks | — |
Countries
Japan
Contacts
Kansai Electric Power Medical Research Institute Division of Translational Diabetology